Mobile UPI  |   About UPI  |   UPI en Español  |   UPI Arabic  |   UPIU  |   My Account
Search:
Go

Science News

Sales Slow for Lipitor, but Pfizer Posts Profit

Oct. 22, 2008
Pfizer said its earnings rose, despite declining sales of some of its key drugs, like Lipitor. Meanwhile, profit at Shering-Plough fell while profit at Biogen surged.
Related Stories from UPI.com

Viracept caution issued by Pfizer

WASHINGTON, Sept. 10 (UPI) -- Pfizer Inc. issued a "Dear Healhcare Professional" letter Monday warning of the presence of an impurity in its Viracept medication.

Nigeria charges Pfizer over drug trial

ABUJA, Nigeria, May 30 (UPI) -- Pfizer faces criminal charges in Nigeria over a drug trial using children during a meningitis epidemic 11 years ago.

Pfizer, pSivida in $165M ophthalmic deal

BOSTON, April 4 (UPI) -- Australian firm pSivida said Wednesday it has entered into a $165 million research and licensing deal with Pfizer.

Pfizer to slash 10,000 jobs, close plants

NEW YORK, Jan. 22 (UPI) -- Pfizer Inc. will slash 10,000 jobs and close plants to cut costs by $2 billion a year by the end of 2008, the pharmaceutical giant said in New York Monday. The job cuts, about 10 percent of its total work force, include more than 20 percent of its Europea

Pfizer discontinues heart disease research

NEW YORK, Dec. 3 (UPI) -- The New York-based pharmaceutical company Pfizer says it has discontinued research on its heart disease drug, torcetrapib.

Pfizer to cut 2,200 members of sales staff

NEW YORK, Nov. 29 (UPI) -- Pfizer Inc., the New York company that makes Lipitor and Celebrex, will lay off about 2,200 U.S. sales personnel as it seeks to become more efficient.

Pfizer acquiring maker of Inovoject

RESEARCH TRIANGLE PARK, N.C., Nov. 15 (UPI) -- Pfizer Animal Health, a division of New York's Pfizer Inc., will spend $155 million for Embrex Inc., maker of the Inovoject vaccine-delivery system.

Pfizer drug found with serious side effect

NEW YORK, Nov. 1 (UPI) -- U.S. pharmaceutical company Pfizer Inc. says clinical trials of its heart medication torcetrapib suggest the drug has a potentially serious side effect.

Pfizer retains Lipitor patent in Austria

NEW YORK, Oct. 17 (UPI) -- The Austrian Patent Office has ruled for Pfizer Inc. in its patent fight over Lipitor's active ingredient against generic drug maker Ranbaxy. Ranbaxy, an Indian company, can appeal the ruling, but the patent will remain in effect during the appeals proces

Ruling upholds Pfizer's Lipitor patent

PRINCETON, N.J., Sept. 13 (UPI) -- Ranbaxy said Wednesday the District Court of The Hague ruled that its generic product violated Pfizer's patent on Lipitor.

Pfizer wins a round against Ranbaxy

THE HAGUE, Netherlands, Sept. 13 (UPI) -- A Dutch court has ruled that Pfizer Inc.'s main patent on the active ingredient in Lipitor stops an Indian generic drug maker from making the chemical.

Pfizer heart pill to be standalone therapy

NEW YORK, July 26 (UPI) -- U.S.-based Pfizer Inc., the world's largest pharmaceutical company, says it has decided to sell a new heart treatment medication as a standalone pill.

Pfizer to manufacture generic Zoloft

NEW YORK, June 29 (UPI) -- Pharmaceutical manufacturer Pfizer Inc. says it will offer a discounted generic version of its drug Zoloft, the nation's best selling antidepressant.

Johnson and Johnson buys Pfizer unit

NEW BRUNSWICK, N.J., June 26 (UPI) -- Johnson & Johnson, which is based in New Jersey, is paying $16.6 billion in cash for the consumer healthcare business of Pfizer Inc.

Pfizer gets bids for consumer med unit

NEW YORK, June 8 (UPI) -- First-round bids for Pfizer Inc.'s consumer products and over-the-counter medicines unit has produced offers near $15 billion from U.S. and British firms.
1 of 28
Lori Anne Madison, 6, competes in Scripps National Spelling Bee
View Caption
Lori Anne Madison, 6, of Woodbridge, Virginia, spells out the letters in her word as she competes during the opening round of the Scripps National Spelling Bee, May 30, 2012, in National Harbor, Maryland. Madison, the youngest known qualifier in the history of the contest, correctly spelled the word "dirigible*", a lighter-than-air aircraft, to advance. UPI/Mike Theiler